Previous 10 | Next 10 |
2023-08-15 14:03:04 ET Legend Biotech Corporation (LEGN) Q2 2023 Earnings Conference Call August 15, 2023, 8:00 AM ET Company Participants Jessie Yeung - Head of Investor Relations and Public Relations Ying Huang - Chief Executive Officer Lori Macomber - Chief Fi...
2023-08-15 06:04:57 ET Legend Biotech press release ( NASDAQ: LEGN ): Q2 GAAP EPS of -$0.57 misses by $0.20 . Revenue of $73.33M (+512.6% Y/Y) beats by $17.09M . License revenue for the three months ended June 30, 2023 was $15.1 million due to the achievement o...
A supplemental Biologics License Application (sBLA) was submitted to the U.S. Food and Drug Administration (FDA) and a Type II Variation Application was submitted to the European Medicines Agency (EMA) by Janssen, seeking approval of CARVYKTI ® ( ciltacabtagene autoleucel; cilt...
2023-08-14 10:17:31 ET Major earnings expected before the bell on Tuesday include: Cardinal Health ( CAH ) The Home Depot ( HD ) Jumia Technologies ( JMIA ) Seadrill ( SDRL ) Sea ( SE ) For further details see: Notable earnings before Tues...
2023-08-07 17:44:22 ET Summary On July 20, Johnson & Johnson, the mastodon of the healthcare sector, released its financial results for the 2nd quarter of 2023. However, those results were overshadowed by a federal judge's decision to dismiss a JNJ subsidiary's bankruptcy fili...
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, will host a conference call for investors at 8:00am Eastern Time on Tuesday, August 15, 2023 to review secon...
2023-07-28 09:47:07 ET More on 2seventy bio 2seventy bio: Nothing Properly Explains The Low Valuation 2seventy bio posts Phase 1 results for CAR-T therapy in bone marrow cancer Bristol Myers, 2seventy bio blood cancer drug Abecma gets review in US, EU, Japan for expa...
2023-07-26 19:30:39 ET Summary Allogene Therapeutics, Inc. is the leading developer of allogeneic CAR-T. There was a time when its logic appealed to me. Lately, however, I have increasingly become disillusioned about its prospects. Lest we forget with all the C-suite...
2023-07-26 07:00:00 ET Summary Baron Health Care Fund invests in companies engaged in the research, development, production, sale, delivery, or distribution of products and services related to the healthcare industry. In the quarter ended June 30, 2023, Baron Health Care Fund adva...
2023-07-20 07:07:34 ET Johnson & Johnson ( NYSE: JNJ ) added ~2% in the pre-market Thursday after the pharma giant exceeded Wall Street forecasts with its Q2 2023 results, thanks mainly to better-than-expected results from its Pharmaceutical and MedTech segments. The New...
News, Short Squeeze, Breakout and More Instantly...
Legend Biotech Corporation Company Name:
LEGN Stock Symbol:
NASDAQ Market:
Legend Biotech Corporation Website:
SOMERSET, N.J., July 10, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Friday, August 9, 2024, to review second-quarter 2024 results. During the webcast and confe...
SOMERSET, N.J., July 02, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today positive overall survival results from CARTITUDE-4, an ongoing, global randomized, open-label Phase 3 study evaluating the efficacy and sa...
2024-06-20 17:01:11 ET USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – June 20,2024 – USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number o...